Skip to main content
logo
Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
34.11
+1.15 (3.49%)
Aug 19, 2026, 4:00 PM EDT - Market closed

Genmab Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
1,1558961,0581,0229257151,027828.58779603705.75668.34611.08413.3738.08538.51444.82316.23400.59359.93
Revenue Growth
24.87%25.31%3.03%23.34%18.74%18.57%45.50%23.98%27.48%45.90%-4.38%24.11%37.38%30.70%84.25%49.61%41.47%26.76%19.25%32.35%
Gross Profit
1,071831977964868673973.83787.75751576687.06657.13608.01413.3738.08538.51444.82316.23400.59359.93
Operating Income
407225243459360188346.99316.92261116259.67239215.1860.81375.43254.43175.4276.71123.74138.68
Net Income
3035331401336195577.85189.35203192104.25298.43195.6830.6373.85340.21266.0269.39109.52138.68
Earnings Per Share
4.910.830.506.465.423.059.002.963.132.941.584.532.970.471.125.164.031.051.662.10
EPS Growth
-9.41%-72.79%-94.44%118.03%73.16%3.74%470.59%-34.60%5.29%531.96%41.20%-12.22%-26.27%-55.78%-32.50%145.90%444.94%-59.86%14.62%65.49%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
DARZALEX Royalties
744562699656638450577557538347483.57445.8428.41281.26416.51401.87355.46223.27301.04281.46
Kesimpta Royalties
143116123122108909584806465.9163.6548.9538.7238.8728.0723.5319.1914.5310.59
TEPEZZA Royalties
3126303020252829232627.8425.5124.9224.1728.6527.2826.9129.631.9734.58
Other Product Royalties
4838313323241521181512.598.797.476.411.871.451.411.041.070.93
Net Product Sales
145116118104101757470624734.3621.265.72-------
Reimbursement
12810713232339424011.1143.3833.4237.1232.2540.4621.4120.0824.4822.43
Milestone
10163153112941-5056.2848.4851.4415.14212.9314.769.1616.5124.489.81
Collaboration
2214161721161715161413.1811.0610.79.758.4923.997.615.53.06-
Revenue (Total)
1,1558961,0581,022925715749.85816779603728.93668.11610.89412.45853.1538.64445.48315.4374.7359.52

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
1,5101,5251,7153,4112,8993,2262,9542,5902,2604,2794,1723,9043,6473,5793,2073,1343,0412,9832,9582,920
Total Debt
5,2735,3515,426142148143144147.62146.4146.08114.19112.48117.7120.985.7882.8889.1962.0865.0168.09
Net Cash (Debt)
-3,763-3,826-3,7113,2692,7513,0832,8102,4432,1144,1334,0583,7923,5303,4593,1223,0512,9522,9212,8932,852
Net Cash Growth
---33.84%30.13%-25.40%-30.76%-35.58%-40.11%19.49%30.00%24.25%19.59%18.41%7.91%6.98%6.19%4.55%11.69%5.54%
Net Cash Per Share
-60.98-59.92-58.8052.6644.3848.2243.7438.2232.6063.2861.4357.5653.6252.5447.2546.2944.7344.2843.7443.17

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
51330153662287423.7304.06219219247.95288.9263.91471.7857.18259.31134.9187.636.8669.65
Capital Expenditures
-2-5-13-2-10-12-14.09-5.68-4-4-9.94-13.9-14.22-15.17-15.8-10.8-9.57-8.51-10.4-12
Free Cash Flow
49-228853452275409.61298.38215215238.02275.0249.69456.6141.38248.5125.3479.0926.4657.65
Free Cash Flow Growth
-5.77%--29.69%78.97%-75.81%27.91%72.09%8.49%332.68%-52.91%475.21%10.67%-60.36%477.31%56.38%331.04%184.81%-56.68%--92.74%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
92.73%92.75%92.34%94.33%93.84%94.13%94.83%95.07%96.41%95.52%97.35%98.32%99.50%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
35.24%25.11%22.97%44.91%38.92%26.29%33.79%38.25%33.50%19.24%36.79%35.76%35.21%14.71%50.87%47.25%39.44%24.26%30.89%38.53%
Pretax Margin
25.54%8.26%5.20%47.16%45.73%34.13%53.94%31.03%39.41%41.29%21.16%56.66%40.63%9.39%11.13%80.06%78.72%28.88%36.88%50.69%
Profit Margin
26.23%5.92%2.93%39.24%36.32%27.27%56.27%22.85%26.06%31.84%14.77%44.65%32.02%7.41%10.01%63.18%59.80%21.94%27.34%38.53%
FCF Margin
4.24%-0.22%27.22%52.25%5.62%38.46%39.89%36.01%27.60%35.66%33.73%41.15%8.13%110.48%5.61%46.15%28.18%25.01%6.61%16.02%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
21.3719.7620.3812.359.8110.5711.3322.3519.9524.8633.1938.8138.5534.6636.8526.9436.2465.7156.0162.77
P/FCF Ratio
19.38-17.0814.6712.3010.2811.5715.9216.8725.2720.4828.2431.0028.2555.8744.1273.29116.1884.71199.36
PS Ratio
4.084.165.285.053.643.684.075.285.777.598.709.5610.7311.5413.5612.4413.9017.3119.8722.72